PrimeRFP SCOUT · Federal Contract Profile

Kiniksa Pharmaceuticals (Uk), Ltd (HBHWNLNMHSV5)Federal contracts · 1 recompete

Kiniksa Pharmaceuticals (Uk), Ltd holds $1.2M in federal volume across 22 award actions, with 78% at Department of Veterans Affairs (VA). SCOUT tracks 1 incumbent recompete — an estimated $220K returning to market over the next 24 months (Low exposure). Primary work: Pharmaceutical Preparation (100% prime). Obligations are down 33% year over year.

$1.2M
Federal Volume
1
Recompetes (24mo)
VA
Top Agency · 78% firm-wide
22
Award Actions

Choose one — this changes what we ask next

Score my firm against Kiniksa Pharmaceuticals (Uk), Ltd

Email me when a Kiniksa Pharmaceuticals (Uk), Ltd recompete window opens.

Data through · refreshed monthly · window Aug 2025 – Aug 2026

Why are you looking at Kiniksa Pharmaceuticals (Uk), Ltd?

Score my firm against Kiniksa Pharmaceuticals (Uk), Ltd

Email me when a Kiniksa Pharmaceuticals (Uk), Ltd recompete window opens.

What they do

Capability

Service lines

PHARMACEUTICAL PREPARATION MANUFACTURING

Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6505 DRUGS AND BIOLOGICALS

Where they win

2 agencies
% of firm-wide obligated ($1.2M) · all agencies

Recompete exposure: Low · 1 in 24mo

Kiniksa Pharmaceuticals (Uk), Ltd has an estimated $220K in contracts returning to market over the next 24 months.

Part of the KINIKSA PHARMACEUTICALS LTD corporate family · 2 entities
Metrics basis: local_db
Recompete exposure & trajectory

Recompete exposure

Low

Kiniksa Pharmaceuticals (Uk), Ltd has an estimated $220K in contracts returning to market over the next 24 months. 1 within 6 months ($220K).

Trajectory
Consolidating-33% YoYFY2025 vs FY2024
'23
'24
'25
SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…
Gwyne Taylor, Tailored Global
Explore another company
Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Kiniksa Pharmaceuticals (Uk), Ltd hold?

Kiniksa Pharmaceuticals (Uk), Ltd (UEI HBHWNLNMHSV5) shows $1.2M across 22 award actions in SCOUT’s public USASpending-backed profile, with Department of Veterans Affairs (VA) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Kiniksa Pharmaceuticals (Uk), Ltd have?

Kiniksa Pharmaceuticals (Uk), Ltd shows $1.2M across 22 award actions. SCOUT tracks 1 incumbent recompetes ($220K) returning to market in the next 24 months.

Which agencies does Kiniksa Pharmaceuticals (Uk), Ltd work with?

Kiniksa Pharmaceuticals (Uk), Ltd’s firm-wide obligated mix is led by Department of Veterans Affairs (VA) (78%), Department of Justice (DOJ) (22%).

What is the UEI for Kiniksa Pharmaceuticals (Uk), Ltd?

The Unique Entity ID (UEI) for Kiniksa Pharmaceuticals (Uk), Ltd is HBHWNLNMHSV5.

Does Kiniksa Pharmaceuticals (Uk), Ltd have contracts coming up for recompete?

Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (Low exposure). Open the recompete section on this page for PIID-level timing.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Sources: USASpending, FPDS, SAM.gov · Data shown is public-record; analysis by PrimeRFP SCOUT. Corpus refreshed Aug 20, 2026. Profile snapshot Aug 19, 2026.
primerfp.com/intel/company/kiniksa-pharmaceuticals-uk-ltd